Articles tagged with Bipolar Disorder
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers have identified a genetic variation linked to bipolar disorder, suggesting that Piccolo contributes to the condition. The study used postmortem tissue and genome-wide association studies to find this link.
A mega-analysis of brain imaging data found that individuals with bipolar disorder who took lithium had increased hippocampal and amygdala volumes compared to those not taking the medication. Lithium treatment also restored cerebral volume reductions associated with longer illness duration.
The Bipolar CHOICE trial will evaluate the real-world advantages and disadvantages of quetiapine compared to lithium for treating outpatients with bipolar disorder. The study aims to inform day-to-day practice in psychiatry with a focus on effectiveness, not just comparing treatments.
A study examining over 3 million veterans found that those with bipolar disorder were more likely to die by suicide than any other psychiatric diagnosis. The risk was highest in men with bipolar disorder, followed by depression, substance use disorders, and PTSD.
A team led by UC San Diego aims to study the genetic bases of bipolar disorder and lithium treatment through a 5-year project, expanding the NIH's Pharmacogenomics Research Network. The goal is to identify key genetic markers to personalize treatment and improve patient outcomes.
A single ketamine dose significantly reduces depressive symptoms within 40 minutes in patients with bipolar disorder who have not responded to other treatments. Approximately 71% of participants experienced a response to ketamine, highlighting its potential as a rapid-acting therapy for treatment-resistant bipolar depression.
Researchers found that an enzyme called prolyl oligopeptidase controls a set of genes related to lithium sensitivity in bipolar patients. This discovery could lead to better understanding of the illness and more effective treatments.
A recent study by MSU psychiatrist Dale D'Mello found that nearly half of patients hospitalized with bipolar disorder also suffer from high blood pressure. The study discovered a link between the severity of bipolar disorders and the level of mania experienced by patients with hypertension.
Researchers have found that lithium reduces brain inflammation by increasing levels of anti-inflammatory DHA and decreasing pro-inflammatory arachidonic acid. This dual mechanism may explain why lithium is effective in treating bipolar disorder, and could lead to additional therapeutic uses.
A study from Rhode Island Hospital found that patients over-diagnosed with bipolar disorder were more likely to receive disability payments for a longer period. The researchers propose a link between the two, suggesting that clinicians may over-diagnose bipolar disorder in complex, chronically ill patients seeking secondary gain.
A new pediatric DSM category, Temper Dysregulation Disorder with Dysphoria (TDD), aims to better reflect symptoms of children currently diagnosed with bipolar disorder. However, the authors argue that this change alone is not enough to promote flourishing in troubled children and may even lead to increased medication use.
Dr. Patrick Sullivan is leading a research project to identify genetic links to psychosis in schizophrenia and bipolar disorder. He will analyze DNA from four families with a high number of affected members to uncover rare genetic variants and compare them to unrelated samples.
A study of copy number variations in the genome found no significant link between these changes and common diseases. However, rare genetic variants and epigenetic factors are believed to play a role in disease susceptibility. The research suggests that focusing on other genetic variations may lead to important advances in human health.
A study published in Experimental Biology and Medicine found that phenytoin modulates gene expression in rats with bipolar disorder, including genes involved in neurotransmission and neuroprotection. The findings suggest that chronic phenytoin administration may have mood-stabilizing effects.
A new study from Rhode Island Hospital has found that a widely-used screening tool for bipolar disorder may incorrectly identify borderline personality disorder. The research team tested the accuracy of the Mood Disorder Questionnaire (MDQ) and found that it misidentified patients with borderline personality disorder, leading to potent...
Troubled children diagnosed with bipolar disorder may benefit from alternative diagnoses like Severe Mood Dysregulation or Temper Dysregulation Disorder. The Hastings Center researchers recommend reframing the diagnosis and treatment approach to address family and social contexts.
Researchers have discovered a possible biomarker for schizophrenia and bipolar disorder using electroretinography, suggesting retinal deficits contribute to perceptual problems. This finding highlights the importance of considering subtle visual issues in individuals with these conditions.
Two Brown University faculty members are awarded federal funding to investigate brain development in infants and children with bipolar disorder. The research aims to identify biological and behavioral markers that distinguish between full-blown and sub-syndromal bipolar disorder, which could lead to more specific diagnoses and treatment.
Research found four alterations in RORB gene associated with pediatric bipolar disorder, linking circadian rhythm abnormalities to the condition. The study suggests that clock genes may be important candidates for further investigation into bipolar disorder's molecular basis.
Researchers at the University of Missouri-Columbia found that nearly half of young adults diagnosed with bipolar disorder between ages 18-25 may recover by age 30. The study suggests a possible link to brain development and social changes during emerging adulthood.
A follow-up study found that patients previously diagnosed with bipolar disorder were more likely to be diagnosed with borderline personality disorder or impulse control disorders. The researchers analyzed 82 psychiatric outpatients who received a previous diagnosis of bipolar disorder, which was not confirmed through the Structured Cl...
A multi-national group of investigators discovered that nearly a third of schizophrenia's genetic basis may be attributed to thousands of common genetic variants. These variants add up to a significant risk for developing both schizophrenia and bipolar disorder.
A new study found that approximately 10% of children with bipolar disorder experience irritable-only mania, and these participants are significantly younger than those with elation-only or both symptoms. The study suggests that irritability should be included in the diagnosis of pediatric bipolar disorder.
A Mayo Clinic study reveals that patients with bipolar disorder incur significantly higher specialty care costs compared to those with diabetes, depression, asthma, or coronary artery disease. Specialty care costs were especially high for bipolar patients, suggesting non-mental health provider-related expenses contribute to the disparity.
Researchers led by Dr. Robert C. Young are conducting studies to investigate the effects of medications on older adults with bipolar depression, aiming to improve treatment outcomes. The studies focus on quetiapine and lamotrigine, and will help better manage care for geriatric bipolar patients.
Researchers at Cardiff University have identified a key molecule involved in Lithium's action on the brain. Increasing IMPase levels can lead to higher PIP3 production, which is reduced by Lithium treatment.
Children and teens of parents with bipolar disorder have an increased risk of developing bipolar spectrum disorder and other psychiatric disorders, according to a study. The risk is higher for those with two parents having bipolar disorder, with an increased likelihood of early-onset bipolar disorder and mood disorders.
Research suggests that people with bipolar disorder are at a higher risk of premature death from medical conditions such as heart disease and diabetes. The study found that the risk is similar for men and women, with endocrine problems also contributing to the increased mortality rate.
A large-scale study of 9 million Swedish individuals reveals that bipolar disorder and schizophrenia share common genetic causes, with heritability rates of 64% and 59%, respectively. This finding challenges the long-held distinction between the two conditions, suggesting a reappraisal of their diagnostic entities.
Researchers at Indiana University have created a comprehensive map of genes likely involved in bipolar disorder, identifying hundreds of genes that contribute to the illness. The study also lays the groundwork for personalized treatments and preventive measures using genetic risk scores.
Researchers found that patients with bipolar disorder have a poorer quality of life than the general population, with factors such as early onset, long-term illness, and tobacco dependence contributing to this effect. In contrast, social support from family can improve quality of life.
A study of 115 children with bipolar disorder found that nearly half continued to experience manic episodes as adults and showed similar rates of substance use disorders. The findings support the existence of child bipolar disorder and highlight the need for further research on its neurobiology and prevention strategies.
A study found that GSK-3-beta is crucial for normal mouse embryonic heart development. Mice lacking this protein died prematurely due to cardiac defects and liver degeneration. The findings suggest caution when considering new GSK-3 inhibitors in women of childbearing age.
A new study published in Biological Psychiatry found that adding N-acetyl cysteine to usual treatment improved depressive symptoms in individuals with bipolar disorder. The study suggests a potential new treatment option for psychiatric disorders, particularly those involving brain glutathione metabolism.
A recent study found that children born to older fathers are at higher risk of developing bipolar disorder. The study, which analyzed data from over 13,000 patients with bipolar disorder, suggests that advancing paternal age may be associated with an increased risk of complex neurodevelopmental disorders.
A study published in Archives of General Psychiatry found that family-focused therapy, combined with medication, significantly reduces depressive symptoms in adolescents with bipolar disorder. The treatment was shown to lead to faster recovery from depressive episodes and improved quality of life.
The ECNP consensus statement on bipolar depression highlights the disease's significant impact on functioning, social relationships, and employment. Early onset of bipolar disorder is associated with a severe burden of disease, particularly during acute depressive episodes.
A large genetic analysis implicates machinery involved in sodium and calcium balance in brain cells in bipolar disorder. Variation in two genes showed the strongest association with bipolar disorder.
A study published in Biological Psychiatry found that individuals with schizophrenia and bipolar disorder share a core set of genes involved in nervous system development and cell death. This common genetic signature may provide a window into discovering new brain mechanisms and effective treatments for these debilitating conditions.
The European College of Neuropsychopharmacology consensus statement highlights differences between unipolar and bipolar depression in diagnosis, epidemiology, and treatment. The statement aims to optimize pharmacotherapy and clinical outcomes for patients with bipolar depression.
A new study by Rhode Island Hospital and Brown University researchers found that bipolar disorder is being overdiagnosed, with 43.4% of patients not receiving a valid diagnosis. This can lead to unnecessary medication side effects, highlighting the need for standardized diagnostic methods.
Researchers found that tamoxifen significantly reduced mania scores and improved patient outcomes in a three-week clinical trial. The study suggests that tamoxifen's effects on protein kinase C may be beneficial for treating bipolar disorder.
Researchers identify distinct biochemical profile in patients with bipolar disorder, suggesting a balance of neurotransmitters is disrupted. The study's findings may lead to the development of more effective treatments using mood-stabilizing drugs like lithium and valproic acid.
A study found that bright light therapy can ease symptoms of bipolar depression in some patients, with optimal response observed at midday. Six out of nine women treated achieved full recovery from depressive symptoms, highlighting the potential of light therapy as an augmentation strategy for improving treatment response.
Research suggests that maintaining consistent sleep schedules and regular physical activity can help balance the circadian system and reduce symptoms of bipolar disorder. Studies found that patients who participated in interpersonal and social rhythm therapy experienced longer periods without new episodes of mania or depression.
Researchers found brain size differences between adolescents with bipolar disorder and schizophrenia, as well as between boys and girls. Puberty may contribute to these changes, suggesting sex hormones influence brain development and potentially informing treatment approaches.
Researchers found increased brain activity in children with bipolar disorder when encoding happy faces and irritability when angry faces, suggesting a neural basis for mania. The study also revealed reduced memory for emotional faces in children with bipolar disorder compared to typically developing peers.
A new study shows that tamoxifen, a breast cancer medication, dramatically reduces manic symptoms of bipolar disorder more quickly than many standard medications. Tamoxifen blocks an enzyme called protein kinase C, which is thought to be over-active during the manic phase.
A new study is providing highly successful parenting skills to parents with bipolar disorder, using the Triple P Positive Parenting Programme. The program has been shown to improve behavior in children and increase parental confidence, particularly for those experiencing instability of mood and behavior.
A study published in Archives of General Psychiatry found a substantial increase in office-based visit diagnoses for bipolar disorder among youth from 1994 to 2003. This growth was accompanied by rising prescription rates for mood stabilizers, antipsychotics, and antidepressants.
The study found that the number of office visits resulting in a bipolar disorder diagnosis for youths ages 19 and younger increased from 25 per 100,000 people in 1994-1995 to 1,003 per 100,000 people in 2002-2003. In contrast, adults saw a rise from 905 per 100,000 people to 1,679 per 100,000 people over the same period.
A preliminary study of 85 patients with bipolar disorder shows that modafinil can improve depressive symptoms, with 44% of participants reporting improved symptoms and 39% experiencing remission after six weeks.
The Bipolar Disorder Phenome Database offers a comprehensive resource for researchers to identify genes linked to bipolar disorder, utilizing over 5,000 patients' clinical data and DNA samples. This database complements existing genetic data and enables researchers to correlate specific symptoms with genetic material.
Researchers at the University of Cincinnati will use functional MRI and MRS to study brain chemistry in response to different treatments. The goal is to better understand the disease, identify early warning signs, and personalize treatment plans.
Researchers at the University of Edinburgh have found that people with bipolar disorder experience accelerated brain tissue loss, particularly in areas controlling memory, face recognition, and coordination. The study shows that repeated episodes of illness can lead to greater brain loss and decline in mental ability.
Research finds genetic links between bipolar disorder and comorbid conditions like anxiety disorders, ADHD, and autoimmune disorders. Comorbidities can complicate treatment and lead to poor health and decreased life expectancy.
Two studies presented at the Seventh International Conference on Bipolar Disorder have identified novel pathways and markers for diagnosing and treating bipolar disorder. The findings suggest a new avenue for treating the underlying cause of the disease, rather than just treating symptoms.
A genome-wide study reveals that variations in multiple genes contribute to the development of bipolar disorder. The researchers identified a promising target gene DGKH, which produces an enzyme involved in lithium's therapeutic effects. This discovery may lead to the development of new and more effective medications for bipolar disorder.
A recent study found that bipolar spectrum disorder affects about 1% of the population, with individuals receiving inadequate treatment. The research highlights the importance of identifying subtypes of bipolar disorder and using appropriate medication to effectively manage symptoms.
A survey estimated that approximately 4.4% of U.S. adults may have some form of bipolar disorder during their lifetime, with 2.4% having a sub-threshold condition. The study found that many individuals with bipolar symptoms receive treatment for depression rather than manic symptoms.